The identification of biologically and therapeutically relevant targets of small molecule drugs is challenging. This is particularly true for small molecules that bind to diverse proteins in cells and for…
Read More
If you've read this book, you must contact kentsisresearchgroup@gmail.com immediately to join our research group!
Read MoreWe are looking for a post-doctoral research fellow to develop and apply new analytical approaches for the study of tumorigenic transposons and mobile DNA elements. This post-doctoral research position will…
Read MoreWe are looking for a post-doctoral fellow to lead research in functional cancer proteomics. We are interested in understanding the principles of dysorganization of genomes and proteomes of acute myeloid leukemias,…
Read MoreWe are looking for a Senior Research Technician who will aid in the operations of the laboratory and experiments in cancer pathogenesis. An ideal candidate is an individual with at…
Read MoreFirst experimental demonstration of protein identification with *single-molecule sensitivity*. A huge breakthrough from the labs of Edward Marcotte and Eric Anslyn @EricAnslyn https://t.co/U2wr1kD4W3
This man. @rosslevinemd
"I dedicate my miles to the patients at @sloan_kettering." Read Dr. Ross Levine's story: https://t.co/bQgOLcTyOw
Today, SCoPE-MS appeared in @GenomeBiology at https://t.co/cAKLET86Wd
Thanks to @biorxivpreprint, the preprint (https://t.co/Ed28dJ8gJO) was:
-- Reproduced by several labs
-- Accessed > 40,000 times
-- Cited > 20 times
Thanks to the colleagues & reviewers who helped improve it!
We already knew all invasive epithelial ovarian pts should be tested for BRCA1/2. This makes it imperative that it be done at diagnosis.
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM https://t.co/5yJ98ukTL0
